Monday, 2 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Other Announcement

JHS Svendgaard Laboratories Other Announcement

JHS Svendgaard filed its quarterly Regulation 32 statement on 2024 preferential issue proceeds. Fund allocation shifted toward capex after shareholder approval; no quarter deviation reported.

Source

BSE filing, NSE: JHS. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

JHS Svendgaard Laboratories Ltd: key numbers

Share price
₹8.30
Market cap
₹71.05 Cr
Revenue (annual)
₹101.7 Cr
Net profit (annual)
₹-1.92 Cr
P/E (TTM)
-37.7×Sector 38.6×
Promoter holding
33.85%+0.00% QoQ
FII holding
2.87%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from JHS Svendgaard Laboratories Ltd

All →

Other other announcement announcements

All →